Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Sigyn Therapeutics, Inc. | s101393_s1a.htm |
| EX-4.1 - EXHIBIT 4.1 - Sigyn Therapeutics, Inc. | s101393_ex4-1.htm |
Exhibit 23.2
August 17, 2015
To the Board of Directors and Stockholders of
Reign Sapphire Corporation
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement on Amendment No. 1 to Form S-1 (No. 333-204486) of our report dated May 26, 2015, relating to the financial statements of Reign Sapphire Corporation (which report expresses an unqualified opinion on the financial statements and includes an explanatory paragraph referring to the Company’s ability to continue as a going concern) for the year ended December 31, 2014 and the period from May 31, 2013 (Inception) through December 31, 2013, which are contained in that Prospectus, which is contained in Part II of this Registration Statement on Amendment No. 1 to Form S-1 (No. 333-204486).
We also consent to the reference to us under the caption “Interests of Named Experts and Counsel” in the Prospectus.
/s/ Hartley Moore Accountancy Corporation
HARTLEY MOORE ACCOUNTANCY CORPORATION
August 17, 2015
Irvine, CA